NCT01372839

Intensive Statin Therapy in PCI Patient With Acute Coronary Syndrome

The Safety and Efficacy of Intensive Statin Therapy in PCI Patient With Acute Coronary Syndrome

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 300 (estimated)
• Sponsor: Xijing Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

Compare with regular regimen, the aim of this study is to testify whether having more statin during PCI will benefit in Chinese population, and to find out optimal dose of the drug for patient after PCI.

Detailed description

This study is designed to find out whether patients undergoing PCI can benefit from intensive atorvastatin treatment compared with routine treatment on chinese population.

Conditions

• Myocardial Infarction
• Unstable Angina

Interventions

Type	Name	Description
DRUG	Atorvastatin	Atorvastatin 80mg/d ×2d before PCI. After PCI, atorvastatin 40mg/d until 30 days later, and then followed by usual care
DRUG	Statin	Usual care, but statin dose should not be higher than that described in exclusion criteria

Timeline

• Start date: 2010-07-01
• Primary completion: 2012-07-01
• First posted: 2011-06-14
• Last updated: 2011-06-14

Locations

1 site across 1 country: China